Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile.
By L. Kyne, M. Hamel, Rajashekhar Polavaram, C. Kelly. Clinical Infectious Diseases, 2002
949 citations recorded by the source corpus.
Subfields: Critical Care and Intensive Care Medicine, Epidemiology, Infectious Diseases
View Paper: https://www.semanticscholar.org/paper/df2f65cb30e6c1d36c327afa7f6932f8166a1d9c
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Critical Care and Intensive Care Medicine
In Epidemiology
- Victor Pham
- Yan Yan
- K. Reske
- A. Butler
- Joshua A. Doherty
- Victoria J. Fraser
- David L. Paterson
- E. Dubberke
In Infectious Diseases
Citations in the corpus
- Emergence of Clostridium difficile-associated disease in North America and Europe. (2006, background): “1 billion per year in the USA [38–41].”
- Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case–control studies (2004, background): “difficile.(5) Use of proton pump inhibitors has been associated with colonization of the normally sterile upper gastrointestinal tract(6) and can therefore alter gastrointestinal flora.”
- Clostridium difficile Toxins: Mechanism of Action and Role in Disease (2005, background): “exceeds 250,000 per year (182), with total additional health care costs approaching US$1 billion annually (98).”
- A Large Outbreak of Clostridium difficile–Associated Disease with an Unexpected Proportion of Deaths and Colectomies at a Teaching Hospital Following Increased Fluoroquinolone Use (2005, methodology): “difficile infection is $3,669 per case.(11)”
- Learning Data-Driven Patient Risk Stratification Models for Clostridium difficile (2014, neutral): “1 billion annually [4].”
- Mortality attributable to nosocomial Clostridium difficile–associated disease during an epidemic caused by a hypervirulent strain in Quebec (2005, background): “Previous studies of the effect of CDAD on costs and durations of hospital stay did not distinguish between the time that case subjects spent in hospital before and after the diagnosis of CDAD.21,24,25 Despite the limitations of our study, our results can be used to estimate the approximate total exc”
- Development and Validation of a Clostridium difficile Infection Risk Prediction Model (2011, background): “Infect Control Hosp Epidemiol 2005;26(3):273–280.”